A 71-year-old woman was admitted with Stanford type A acute aortic dissection (AAD). Computed tomography (CT) revealed thrombosis of the false lumen, and we planned to treat medically. She developed transient pleural effusion and hypoxemia, which persisted despite her pleural effusion disappeared. We performed CT and found a large thrombus in the pulmonary artery and femoral vein. We administered low doseunfractionated heparin and installed a retrievable inferior vena cava fi lter, which caused the thrombus in the pulmonary artery to disappeared without exacerbating AAD. Our strategy seems to be suitable for acute pulmonary thromboembolism that occurs during the treatment of AAD.
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Keywords: acute aortic dissection, acute pulmonary thromboembolism, deep vein thrombosis auscultation, respiratory sounds were clear, and no murmurs were detected. A laboratory examination demonstrated a white blood cell count of 12100/µL, a hemoglobin concentration of 13.0 mg/dL, and a platelet count of 22.9 × 10 4 /µL. Blood biochemical tests produced normal results, including an aspartate aminotransferase level of 17 IU/L, an alanine aminotransferase concentration of 15 IU/L, a creatinine kinase concentration of 71 IU/L, and a creatinine level of 0.58 mg/dL. A troponin T test produced negative results. However, a coagulation test showed that the patient's D-dimer (60.9 µg/mL) levels were markedly elevated. Electrocardiography revealed a normal sinus rhythm, and did not detect any signifi cant ST-T wave changes (Fig. 1) . Chest radiography demonstrated mediastinal widening, but no pleural effusion was observed (Fig. 2) . Contrast-enhanced computed tomography (CT) depicted an acute aortic dissection (AAD), which extended from the ascending aorta to the common iliac artery (Fig. 3) . A transthoracic echocardiographic examination did not detect any aortic regurgitation, pericardial effusion, or dilatation of right heart. So, we diagnosed the patient with a Stanford type A AAD. As complete thrombosis of the aortic false lumen was achieved on admission, the patient was treated with antihypertensive agents.
The clinical course of the patient's AAD was good, and she underwent rehabilitation according to the program recommended by the appropriate treatment guidelines. 1) However, transient pleural effusion was showed to develop on chest radiography of day 4, and we considered that this would reduce the patient's oxygen saturation level. Although the pleural effusion subsequently disappeared on chest radiography of day 12, the patient's oxygen saturation level remained low (about 85%) in room air. Rehabilitation did not progress because of hypoxemia, and sometimes she walked only in the room with oxygen
Case Report
A 71-year-old woman with a history of hypertension suffered a 2-hour episode of sudden severe back pain and visited our hospital. Her height was 160 cm and her weight was 70 kg. Her blood pressure was 170/90 mmHg in both arms, her heart rate was 55 beats per minute, and her oxygen saturation level was 100% in room air. On inhalation. We wondered the reason of hypoxemia and considered the possibility of other coexisting disease such as pneumonia, atelectasis, pneumothorax, pulmonary thromboembolism and so on.
On day 17, we performed contrast-enhanced CT in order to follow-up the patient's AAD and investigate the cause of her hypoxemia. As a result, thrombi were detected in the right main pulmonary artery and left femoral vein (Fig. 4) . In addition, an echocardiographic examination detected right ventricular overload (transtricuspid pressure gradient was 34 mmHg). So, we fi nally diagnosed the patient with a submassive acute pulmonary thromboembolism (APTE) and proximal deep vein thrombosis (DVT) that had developed during treatment for a Stanford type A AAD although she wore an elastic stocking from admission . Fibrinolysis was diffi cult in the present case as the patient was in the acute phase of AAD, so we installed an inferior vena cava (IVC) fi lter and started careful anticoagulation therapy to prevent her AAD worsening. After the initiation of anticoagulation therapy, the patient's oxygenation level improved immediately. We adjusted the amount of unfractionated heparin administered to achieve an activated partial thromboplastin time of about 45 s. The right ventricular overload was shown to disappear by a transthoracic echocardiographic examination on day 26. After confi rming that we were able to achieve suffi cient anticoagulation without the patient's AAD worsening, we retrieved the IVC fi lter on day 34 after admission (17 days after the implantation of the IVC fi lter). A test for hereditary thrombophilia was negative, and it was considered that hypercoagulability was the only likely cause of subsequent thromboses during the repair of the AAD. After receiving warfarin-based anticoagulation therapy, the patient was discharged on day 39. A CT scan performed at 4 months after discharge did not detect any residual thrombi in the pulmonary artery or femoral vein, and the patient's AAD had not worsened.
Discussion
It is necessary for patients to rest during medical treatment for AAD, 1) and they are considered to be at high risk of APTE. Furthermore, hypercoagulability can develop during the acute phase of AAD, resulting in a high risk of venous thromboembolism. On the other hand, anticoagulation therapy can cause AAD to worsen, resulting in the recanalization of false lumens and re-dissection. In a previous study, 2 of 129 cases (1.6%) of Stanford B AAD were complicated by APTE during medical treatment. 2) There have been several reports about APTE and DVT occurring during medical treatment for AAD although there were few similarities between the cases (Table 1) . Currently, there are no standard treatments for APTE and DVT that occur during medical treatment for AAD. We this case fortunately, but we cannot suggest how to apply the anticoagulant therapy to those patients from this case alone. Further consideration in more cases is needed. The treatment for dissection with thrombosed false lumen at the ascending aorta is still controversial. [8] [9] [10] Like this case, if the frequency of venous thrombosis with ADD is higher with the patient performed medical therapy than surgical, it might be one of the reasons that surgical therapy is recommended for the treatment of ADD.
We need additional evidence about this.
In conclusion, it is important to prevent venous thromboembolisms during medical treatment for AAD. Hypoxemia should be carefully treated whether venous thromboembolisms happen or not, like this case. In AAD patients who subsequently develop APTE, clinicians should consider the state of the AAD and APTE when they decides on the most appropriate treatment. We do not conclude or suggest any effi cacy of IVC fi lter from this case, but installing a retrievable IVC fi lter and administering anticoagulation therapy might be one of the appropriate treatments for patients that develop APTE during the acute phase of AAD.
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The authors state that they have no confl icts of interest to declare. considered thrombectomy at this time. But, as she was hemodynamically stable and duration of contraindication to adequate anticoagulant might be temporal, we selected medical therapy with less-invasive IVC fi lter implantation as fi rst choice. Also, we installed an IVC fi lter because we could not be certain that anticoagulation therapy would achieve the target therapeutic range in such an acute phase of AAD. After the initiation of anticoagulation therapy, the false lumen in the descending aorta tended to enlarge. However, it did not worsen further after that point. In cases in which the risk of re-dissection increases or a false lumen enlarges during medical therapy, stent grafting might be indicated depending on the anatomical location. 6) We employed a retrievable IVC fi lter in the present case, and it was considered that this would be suffi cient providing that the patient's AAD and hypercoagulability improved and that she could be released from the requirement to rest. If anticoagulation therapy had not been successful, we planned to replace the retrievable IVC fi lter with a permanent one. However, permanent IVC fi lters can cause DVT to relapse, as demonstrated by the Prevention du Risque d'Embolie Pulmonaire par Interruption Cave (PREPIC) study. 7) Fortunately, the patient's clinical course and CT fi ndings were favorable, so we decided to retrieve the IVC fi lter.
This does not indicate that anticoagulation therapy is safe for all AAD patients. The dose and timing of anticoagulant therapy are thought to be important. We succeeded 
